Form 10-Q GeneDx Holdings Corp. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
GeneDx (WGS) PT Raised to $45 at BTIG
July 31, 2024 4:57 AM EDTBTIG analyst Mark Massaro raised the price target on GeneDx (NASDAQ: WGS) to $45.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Shares of WGS are indicating up +10% AH following another strong quarterly beat-and-raise. WGS drove a ~$10M revenue beat (~16%... More
